APA (7th ed.) Citation

JA, M., R, J., LE, M., CS, P., A, A., EJ, D., . . . BN, W. (2026). The CLTI Paradigm Shift: Implications for Clinical Trial Design and Endpoints in Endovascular Management of Infrapopliteal Disease. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 33(5), 2325. https://doi.org/10.1177/15266028251363541

Chicago Style (17th ed.) Citation

JA, Mustapha, Jacob R, Miller LE, Pena CS, AlMahameed A, Dippel EJ, Beasley RE, and Wiechmann BN. "The CLTI Paradigm Shift: Implications for Clinical Trial Design and Endpoints in Endovascular Management of Infrapopliteal Disease." Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists 33, no. 5 (2026): 2325. https://doi.org/10.1177/15266028251363541.

MLA (9th ed.) Citation

JA, Mustapha, et al. "The CLTI Paradigm Shift: Implications for Clinical Trial Design and Endpoints in Endovascular Management of Infrapopliteal Disease." Journal of Endovascular Therapy : An Official Journal of the International Society of Endovascular Specialists, vol. 33, no. 5, 2026, p. 2325, https://doi.org/10.1177/15266028251363541.